---
document_datetime: 2023-09-21 17:15:48
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/atosiban-sun-epar-all-authorised-presentations_en.pdf
document_name: atosiban-sun-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7618575
conversion_datetime: 2025-12-15 02:41:04.959899
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength       | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|----------------|---------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/13/852/001  | Atosiban SUN      | 6.75 mg/0.9 ml | Solution for injection                | Intravenous use           | vial (glass)          | 0.9 ml                    | 1 vial      |
| EU/1/13/852/002  | Atosiban SUN      | 37.5 mg/5 ml   | Concentrate for solution for infusion |                           | vial (glass)          | 5 ml                      | 1 vial      |